2019 — Barcelona, Spain • September 23 to September 26
September 22—DSP and Board Meeting
September 23—CE Courses
September 24–September 26—Scientific Sessions
2018 — Washington, DC • September 29 to October 3
Scientific topics Covered: Science=Solutions for the US Opioid Crisis, The Promise and Perils of Heart Failure Gene Therapy, Secondary Pharmacology: From the Test Tube to the Clinic, Next Generation Non-Opiate Pain Management, Safety Pharmacology/FDA Discussion on the Gastrointestinal System, CiPA Real-Life Implementation, Cardio-Oncology, Central Nervous System and Sensory Assessments: Established and Emerging Nonclinical Drug Safety Testing Strategies, Advanced Imaging Techniques in Preclinical Safety, In Silico Approaches, From Bench to Bedside—Translational Clinical Pharmacology Designs, and Interactive Case Studies.
2017 — Berlin, Germany • September 23 to 27
Scientific topics Covered: Gender Differences in Cardiovascular Diseases, The Pathophysiology and Treatment of Tinnitus, Oncology Drug Safety Testing in the 21st Century, Updates on the Hot Topics within CNS, Current Topics in the Translation and Validation of Safety Pharmacology Studies, Best Practices for New Biological Entities and New Modalities, Disease Models and Personalized Medicine, In Vitro Microphysiological Systems to Predict Safety, In Silico Modeling for Cardiac Drug Safety, Animal Models and Species Selection, CiPA Challenges and Opportunities from Nonclinical, Clinical, and Regulatory Perspectives and Interactive Case Studies.
2016 — Vancouver, Canada • September 18 to 21
Scientific topics Covered: Safety Pharmacology Across the Globe, Translational Cardiovascular Safety Pharmacology, Receptor Pharmacology, Advances in Technologies: In Vitro and In Silico Models, Practical Pharmacology, Personalized Medicine, Translational CNS and Respiratory Safety Pharmacology, State-of-the-Art Technologies and Methods, Translational Biomarkers: Bridging the Gap, Paediatric & Fetal Clinical Pharmacology, Regulatory Session, as well as SPS Oral Communications (from posters) and CSPT Trainee Presentations (from posters).
2019 Regional Meeting Information Will Become Available As Soon As Meeting Dates and Location Are Confirmed
Past Regional Meetings
To view information from previous regional meetings, please click here.
Distinguished Service Award
The Safety Pharmacology Society Distinguished Service Award (DSA) is an honor given to an individual who has substantially contributed to the field of Safety Pharmacology in one or more of the following areas: specific research achievements, champions of the field, lifelong contribution to the field, substantial specific contribution, visionary direction, regulatory decisions, science and technology of the field, education, mentorship in the field, collaboration between industry, academia, and regulatory.
Previous Distinguished Service Award Recipients
Junior Investigator Award
Eligible candidates for the Junior Investigator Award include students (undergraduate or graduate), technical staff, and junior scientists, postdoctoral fellows (< 5 years), and early career lab heads. The candidate should have less than 10 years experience in the field of safety pharmacology. Candidates may come from within academia, contract research organizations, pharmaceutical or biotechnology industry, government or engaged in preclinical research in safety pharmacology.
Exclusion criteria include previous Junior Travel Award winners, professors (undergraduate or graduate programs) and management personnel (e.g. laboratory head, principal investigator, or supervisor/mentor).
Previous Junior Investigator Award Recipients